Oncology Pharma (ONPH) News Today $0.0002 +0.00 (+100.00%) As of 08/7/2025 12:38 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock ONPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period ONPH Oncology Pharma Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comIndian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 MillionMarch 10, 2025 | forbes.comCardiff Oncology: Some Data Are In; Here's What You Should Know And Look For NextNovember 7, 2024 | seekingalpha.comFoghorn Therapeutics Advances Oncology Pipeline with New TrialsNovember 5, 2024 | markets.businessinsider.comAstellas: Can The Gastric Cancer Approval Be The Inflection Point?October 30, 2024 | seekingalpha.comPfizer's Oncology Triumphs Keep Investors Hooked Amid Market VolatilityOctober 29, 2024 | seekingalpha.comPlant fungus provides new drug target for colorectal cancer therapyOctober 18, 2024 | msn.comCircle Pharma Announces First Patients Dosed in Phase 1 Clinical Trial of First-in-Class Oral Cyclin A/B RxL Inhibitor CID-078 for Advanced Solid TumorsOctober 16, 2024 | businesswire.comPersonalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against CancerOctober 10, 2024 | benzinga.comMeet the founder searching for the ‘holy grail’ of cancer treatmentOctober 8, 2024 | msn.comSun Pharma inks licensing pact with Philogen for cancer medicationOctober 1, 2024 | msn.comSun Pharma Expands Its Oncology Pipeline: What Does This Mean for Investors?October 1, 2024 | msn.comIGM Biosciences to minimize spending on oncology candidates, appoints new CEOSeptember 30, 2024 | msn.comBoehringer Ingelheim opens $66.8m new cancer research facilitySeptember 28, 2024 | msn.comClinical cancer research in the US is increasingly dominated by pharmaceutical industry sponsors, study findsSeptember 28, 2024 | msn.comCrucial role of oncology pharmacists celebrated on World Pharmacist DaySeptember 27, 2024 | msn.comPPARs and PROTACs: A new strategy in cancer therapeuticsSeptember 13, 2024 | msn.comTransgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of InnovationSeptember 11, 2024 | markets.businessinsider.comCG Oncology: Promising Data, But Looks ExpensiveAugust 26, 2024 | seekingalpha.comCancer: 'Natural, Less Toxic' Chemo Alternative May Be on HorizonAugust 24, 2024 | msn.comBioNTech says FDA lifts partial hold on its cancer drug trialAugust 19, 2024 | reuters.comOptimistic Outlook on Oric Pharmaceuticals’ Cancer Therapy Pipeline and Strategic PartnershipsAugust 16, 2024 | markets.businessinsider.comPanavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer MedicineAugust 15, 2024 | markets.businessinsider.comPredictive Oncology Inc. (POAI) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comNew vaccine against cervical cancer combines prophylactic and therapeutic activityAugust 15, 2024 | msn.comEndometrial cancer patients see new hope as FDA approves 'transforming' immunotherapy drugAugust 8, 2024 | msn.comNuvectis Pharma: Strong Buy Rating on Solid Financials and Promising Oncology PipelineAugust 6, 2024 | markets.businessinsider.comOncology Pharma Inc (ONPH)August 3, 2024 | uk.investing.comJapan's Otsuka Pharma to pay up to $1.1 billion to acquire Jnana TherapeuticsAugust 1, 2024 | yahoo.comTargeting oncogenic transcription factors to develop potential new cancer treatmentsJuly 31, 2024 | msn.comPfizer's Upgraded Oncology Segment Powers Second-Quarter GrowthJuly 30, 2024 | fool.comDenver co. spent millions to make a cancer drug it can't sell, but it's growing anywayJuly 29, 2024 | bizjournals.comPfizer Q2 Earnings Preview: Focus on oncology, obesity treatmentsJuly 29, 2024 | msn.comRx plant spent millions readying cancer drug. Now it can't sell it.July 26, 2024 | bizjournals.comDay One scores $111 million in licensing deal for child brain cancer drugJuly 25, 2024 | bizjournals.comWeston company receives FDA designation for pancreatic cancer drugMay 22, 2024 | bizjournals.comGlobal Pharma Giants Are Betting Big On Oncology But Without Daring To Tackle Cancer PreventionMay 22, 2024 | benzinga.comEU regulator scraps approval for pregnancy drug over cancer riskMay 18, 2024 | reuters.comAmerican Oncology Network GAAP EPS of -$1.22, revenue of $364.34MMay 16, 2024 | msn.comEnding Oncology's Toxic Relationship With High Chemotherapy DosesMay 10, 2024 | msn.comThe FDA targets pharma’s grip on costly, toxic cancer drug dosagesMay 7, 2024 | msn.comCoach's death spotlights pharma's profit wins in chemo drug shortageMay 3, 2024 | news.yahoo.comNovartis to Buy Mariana Oncology for Up to $1.75 Bln in Boost to Radioligand Therapy BusinessMay 2, 2024 | marketwatch.comONO to acquire Deciphera Pharmaceuticals in $2.4B dealApril 30, 2024 | msn.comJapan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansionApril 30, 2024 | yahoo.comWhy Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?April 29, 2024 | benzinga.comDeciphera stock soars after Ono Pharmaceutical’s $2.4B buyout dealApril 29, 2024 | msn.comPeninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kidsApril 23, 2024 | bizjournals.comNika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary SupplementApril 17, 2024 | markets.businessinsider.comNuclear Medicine Is Big Pharma’s New Target in Cancer RaceApril 12, 2024 | bloomberg.com Get Oncology Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPH and its competitors with MarketBeat's FREE daily newsletter. Email Address ONPH Media Mentions By Week ONPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONPH News Sentiment▼0.000.39▲Average Medical News Sentiment ONPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONPH Articles This Week▼00▲ONPH Articles Average Week Get Oncology Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies American Green News Today AppTech Payments News Today Arbe Robotics News Today Artificial Intelligence Technology Solutions News Today Artificial Life News Today Aurora Innovation News Today Banzai International News Today Beamr Imaging News Today CareCloud News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ONPH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncology Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
